Published in:
01-08-2006 | Adis Drug Profile
Intravenous Ibandronate in the Treatment of Osteoporosis
A Viewpoint by Silvano Adami
Author:
Silvano Adami
Published in:
Drugs
|
Issue 12/2006
Login to get access
Excerpt
Bisphosphonates are considered the first-line option for the treatment of postmenopausal osteoporosis. However, the available oral formulations cannot be taken by patients with a number of conditions, such as those with oesophageal abnormalities, cognitive difficulties or inability to follow dose administration instructions (e.g. bedridden) or those taking multiple oral medications. …